Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000390845 | SCV000334104 | uncertain significance | not provided | 2015-08-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000390845 | SCV001083001 | benign | not provided | 2024-04-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004984775 | SCV005604056 | likely benign | Inborn genetic diseases | 2024-08-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001828186 | SCV002077909 | likely benign | Progressive familial intrahepatic cholestasis type 2 | 2020-01-31 | no assertion criteria provided | clinical testing |